COMMUNIQUÉS West-GlobeNewswire

Axovant Sciences Announces Public Offering of Common Shares
13/12/2018
BASEL, Switzerland, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (Nasdaq: AXON) ("Axovant") today announced that it has commenced an underwritten public offering of its common shares. All of the common shares are [...]
Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
13/12/2018
Expects to Announce Results of Meeting After Receipt of Final Minutes from FDA PRINCETON, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced [...]
Ziopharm Oncology Promotes Dr. David Mauney to President
13/12/2018
BOSTON, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that David Mauney, M.D., has been promoted to President effective immediately. Dr. Mauney, who joined Ziopharm in 2017 as [...]
Conformis Announces Strategic Actions to Reach Profitability and Reduce Debt
13/12/2018
Conformis Provides 2019 Cost & Debt Reduction Initiatives Optimize sales, marketing and administrative expense to take advantage of recently achieved gross margin & operational efficiencies Sharpen focus on new [...]
OrthoPediatrics Corp. Announces Full-Scale U.S. Launch of Small Stature Scoliosis System
13/12/2018
WARSAW, Ind., Dec. 13, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today the full-scale U.S. launch of its 26 [...]
National Institute on Drug Abuse Presents Data on Trevena’s TRV734 at the 57th Annual Meeting of the American College of Neuropsychopharmacology
13/12/2018
CHESTERBROOK, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in [...]
Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
13/12/2018
Two novel programs for fatal pediatric diseases deepen Axovant’s neurological gene therapy pipeline AXO-AAV-GM1 expected to enter the clinic in first half 2019, with initial data expected in second half 2019 First [...]
Pediapharm Announces Name Change, Consolidation and Debenture Repayment
13/12/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Dec. 13, [...]
Algae Biomass Organization Bringing 2019 Algae Biomass Summit to Orlando, Florida
13/12/2018
Largest algae conference in the world now accepting abstracts and proposals for advances in algae for food and feed, biofuels and biomaterials, water, air and soil ORLANDO, Fla., Dec. 13, 2018 (GLOBE NEWSWIRE) -- The [...]
Diffusion Pharmaceuticals Announces 1-for-15 Reverse Stock Split As Part Of NASDAQ Compliance Plan
13/12/2018
CHARLOTTESVILLE, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving [...]
Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)
13/12/2018
Two participating clinical trials centers now open for enrollment LOS ALTOS, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today that it has begun enrollment of the first patients and has started dosing [...]
Guardant Health Partners with AstraZeneca to Develop Blood-Based Companion Diagnostic Tests for Tagrisso and Imfinzi
13/12/2018
FDA grants breakthrough device designation to GuardantOMNI test used for plasma-based tumor mutational burden analysis in AstraZeneca trial Agreement covers immunotherapy and targeted therapy compounds REDWOOD CITY, [...]
Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M
13/12/2018
Press Release 13 December 2018 Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF [...]
Reminder- Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease Tomorrow
13/12/2018
For those who are unable to attend in person, a live webcast and replay will be accessible here HAIFA, Israel, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading [...]
XBiotech annonce la publication de l'analyse post-hoc pour une étude sur le cancer colorectal de Phase III
13/12/2018
Les biomarqueurs prédisent des taux de réponse au traitement au bermekimab considérablement plus élevés chez les patients atteints d'un cancer de stade avancé AUSTIN, Texas, 13 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc [...]
Mariner Endosurgery Wins FDA Clearance for Groundbreaking Augmented Surgical System LaparoGuard
13/12/2018
New navigation system brings surgeons unprecedented 3D spatial awareness during minimally invasive abdominal procedures Washington, DC, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Following months of review, the US Food and Drug [...]
Sharecare launches Sharecare Rx to help make medications more affordable and convenient
13/12/2018
Sharecare expands its dynamic personal health management platform with new digital pharmacy savings card powered by CVS Caremark for generic and branded medications; adds drug safety information, motivation and support [...]
VBI Vaccines Announces Pricing of $37.5 Million Public Offering
13/12/2018
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
13/12/2018
Preclinical Data for APVO436 Show Potential Best-in-Class Attributes with Potent T-Cell Directed Tumor Killing and Reduced Cytokine Production Compared to a Competitor Construct Phase 1/1b Clinical Trial to Evaluate [...]

Pages